Mid‐Term Clinical Outcomes According to CTO Revascularization Status in Patients With NSTEMI and Multivessel Disease
Clinical Cardiology · 2026
DOI: 10.1002/clc.70491 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Wei Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Coronary Occlusion, Non-ST Elevated Myocardial Infarction, Percutaneous Coronary Intervention. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xuzhou National Clinical Key Specialty Cultivation Project.
Abstract (Originalsprache)
Background
The clinical relevance of chronic total occlusion (CTO) revascularization in patients with non–ST‐segment elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) remains uncertain.
Methods
In this multicenter retrospective cohort study, 632 patients with NSTEMI, MVD, and CTO were included. Patients were categorized into a complete revascularization group involving successful CTO recanalization (CR‐CTO, n = 119) and an incomplete revascularization group without successful CTO recanalization (ICR‐CTO, n = 513). The primary endpoints were major adverse cardiovascular and cerebrovascular events (MACCE) and major adverse cardiovascular events (MACE).
Results
During a mean follow‐up of 528 ± 201 days, the incidences of MACCE (11.8% vs. 28.5%) and MACE (7.6% vs. 24.2%) were significantly lower in the CR‐CTO group than in the ICR‐CTO group (both p < 0.001). In multivariable Cox regression analyses, CR‐CTO was independently associated with lower risks of MACCE (hazard ratio [HR], 0.35; 95% confidence interval [CI], 0.20–0.61) and MACE (HR, 0.26; 95% CI, 0.13–0.51). Among patients without successful CTO recanalization, additional revascularization of non‐CTO lesions was not associated with improved outcomes.
Conclusions
In patients with NSTEMI, MVD, and CTO, complete revascularization involving successful CTO recanalization was associated with improved mid‐term clinical outcomes. In contrast, additional revascularization of non‐CTO lesions alone was not associated with a prognostic benefit when CTO lesions remained unrevascularized. These findings suggest that CTO revascularization status may warrant specific consideration when revascularization strategies are evaluated in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical College of Xuzhou Medical University, Xuzhou, Jiangsu, China.
- Department of Cardiology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China.
- Department of Ultrasonography, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China.
- Department of Cardiology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
- Department of Cardiology, Cangzhou People's Hospital, Cangzhou, Hebei, China.
- Department of Information Center, Yuncheng Central Hospital, Yuncheng, Shanxi, China.
ORCID-Profile: Wei Liu, Yuling Li, Chongyou Rao, Bing Han
Förderung
- Xuzhou National Clinical Key Specialty Cultivation Project
Zitieren
APA
Liu, W., Li, Y., Qin, W., Gao, J., Liu, B., Rao, C., & Han, B. (2026). Mid‐Term Clinical Outcomes According to CTO Revascularization Status in Patients With NSTEMI and Multivessel Disease. Clinical Cardiology. https://doi.org/10.1002/clc.70491
Vancouver
Liu W, Li Y, Qin W, Gao J, Liu B, Rao C, et al. Mid‐Term Clinical Outcomes According to CTO Revascularization Status in Patients With NSTEMI and Multivessel Disease. Clinical Cardiology. 2026. doi:10.1002/clc.70491
BibTeX
@article{Liu2026,
author = {Liu, Wei and Li, Yuling and Qin, Wei and Gao, Jixian and Liu, Bo and Rao, Chongyou and Han, Bing},
title = {Mid‐Term Clinical Outcomes According to CTO Revascularization Status in Patients With NSTEMI and Multivessel Disease},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70491}
}
EUVIMED